alzheimer's semaglutide ameliorates disease and restores oxytocin in APP/PS1 mice and human brain organoid models Semaglutide may reduce Alzheimer's risk

October 2025: A groundbreaking study has discovered that people who take Rybelsus or other semaglutide drugs for diabetes are over four times more likely to be diagnosed with non-arteritic anterior ischemic optic neuropathy (a type of vision loss) than those who do not

10/9/24 Update: The FDA has recently marked the tirzepatide shortage status as Resolved. However semaglutide remains in shortage status

Proper storage is crucial for maintaining the effectiveness of the mixed solution

Conclusion Incorporating probiotic supplements into the treatment plan for individuals using GLP-1 receptor agonists may offer multiple benefits, including the reduction of gastrointestinal side effects, enhancement of weight loss, and improvement of metabolic health

Given about 2 in 5 American adults are obese, curbing this chronic medical condition could have dramatic effects in decreasing the incidence of cancer